Outcome of rapid disease progression in the treatment break following cytoreductive nephrectomy (CN) after presurgical sunitinib in patients with primary metastatic renal cell carcinoma (RCC).

Axel Bex,Thomas Powles,Christian U. Blank,Simon Chowdhury,Simon Horenblas,John Peters,Ekaterini Boleti,John B. A. G. Haanen

Outcome of rapid disease progression in the treatment break following cytoreductive nephrectomy (CN) after presurgical sunitinib in patients with primary metastatic renal cell carcinoma (RCC).

2017

Axel Bex
Thomas Powles
Christian U. Blank
Simon Chowdhury
Simon Horenblas
John Peters
Ekaterini Boleti
John B. A. G. Haanen

4611 Background: There is concern that interruption of tyrosine kinase inhibitors (TKI) triggers disease progression (PD) and metastasis. This is based on preclinical models and observation of rapi...

Keywords:

Pathology
Disease
Rapid disease progression
Oncology
Nephrectomy
Metastasis
Renal cell carcinoma
Internal medicine
Tyrosine kinase
Sunitinib
Medicine
disease progression
in patient
cytoreductive nephrectomy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations